Therapeutics: Metabotropic glutamate receptor subtype 5 (mGluR5; GRM5);

Neurology

INDICATION: Schizophrenia

In vitro and rat studies identified a positive allosteric modulator (PAM) of mGluR5

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE